IPCA Laboratories hits 52-week high ahead of Q4 results

Stock up over 2% at Rs 615.80

IPCA Laboratories gained over 2% and is currently trading at its 52-week high at Rs 615.80 ahead of its March quarter numbers which is expected today.
 
The pharma company is expected to report a 10% year-on-year jump in net profit to Rs 84 crore as compared to Rs 76 crore reported in the same period a year ago.
 
The stock opened at Rs 595 and has hit a high of Rs 615.80 and a low of Rs 593.80 thus far in morning trades. A combined, over 45,000 shares have changed hands on the BSE and NSE.